Latest AI and machine learning research in oncology/hematology for healthcare professionals.
INTRODUCTION: Integrating decision support mechanisms utilising artificial intelligence (AI) into medical radiation practice introduces unique challenges to accountability for patient care outcomes. AI systems, often seen as "black boxes," can obscure decision-making processes, raising concerns about practitioner responsibility, especially in adverse outcomes. This study examines how medical radia...
Lung cancer, which claims 1.8Ā million lives annually, is still one of the leading causes of cancer-related deaths globally. Patients with lung cancer frequently have a bad prognosis because of late-stage detection, which severely limits treatment options and decreases survival rates. Early detection is essential for better outcomes, but traditional CT image analysis is time-consuming, prone to err...
Breast cancer (BRCA) continues to pose a serious risk to women's health worldwide. Neoadjuvant chemotherapy (NAC) is a critical treatment strategy. Ne...
This study measures expression of () and related cytokine genes in bone marrow mononuclear cells in patients with hematological malignancies, analyzi...
Non-invasive diagnostic monitoring techniques have become essential for treating lung cancer (LC), which continues to be the primary cause of cancer-r...
Early screening for cancer has proven to improve the survival rate and spare patients from intensive and costly treatments due to late diagnosis. Canc...
The high morbidity and mortality of hepatocellular carcinoma (HCC) impose a substantial economic burden on patients' families and society, and the maj...
Lung cancer remains the leading cause of cancer-related mortality worldwide, with its early detection and effective treatment posing significant clini...
The expression levels of microRNAs (miRNAs) are strongly linked to cancer progression, making them promising biomarkers for cancer detection. Enzyme-f...
PURPOSE: To assess the predictive capability of CT radiomics features for early recurrence (ER) of pancreatic ductal adenocarcinoma (PDAC).
Esophageal cancer (EC) is one of the leading causes of cancer-related mortality worldwide, still faces significant challenges in early diagnosis and p...
Chimeric antigen receptor (CAR) TĀ cell immunotherapy represents a breakthrough in the treatment of hematological malignancies, but poor specificity ha...
Over the past several decades, there has been a significant increase in the number of breast cancer patients. Among the four subtypes of breast cancer...
This study examines GPT-4o's ability to communicate effectively with relatives of patients undergoing decompressive hemicraniectomy (DHC) after malig...
PURPOSE: Cetuximab (CET), targeting the epidermal growth factor receptor, is a systemic treatment option for patients with colorectal cancer. One know...
RATIONALE AND OBJECTIVES: To develop and validate a computed tomography (CT)Ā radiomics-based interpretable machine learning (ML) model for predicting ...
Cancer drug resistance poses a significant challenge in oncology, primarily driven by cancer cell plasticity, which promotes tumor initiation, progres...
The efficiency of sensor arrays in parallel discrimination of multianalytes is fundamentally influenced by the quantity and performance of the sensor ...
MXenes and their composites exhibit remarkable electrical conductivity, mechanical flexibility, and biocompatibility, making them ideal candidates for...
Drug response prediction (DRP) is a central task in the era of precision medicine. Over the past decade, the emergence of deep learning (DL) has great...